1Jimenez - Cervantes C, Martinez - Esparza M, Perez C, et al. Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor. J Cell Sci, 2001, 114 (Pt 12) :2335 -2344.
2Schallreuter KU, Moore J, Wood JM, et al. Epidermal H (2) O (2)accumulation alters tetrahydrobiopterin ( 6BH4 ) recycling in vitiligo:identification of a general mechanism in regulation of all 6BH4 - dependent processes? J Invest Dermatol, 2001, 116 (1) :167 -174.
3Schallreuter KU, Wood JM, Pittelkow MR, et al. Increased monoamine oxidase A activity in the epidermis of patients with vitiligo. Arch Dermatol Res, 1996, 288(1) :14 -18.
4Schallreuter KU. A review of recent advances on the regulation of pigmentation in the human epidermis. Cell Mol Biol (Noisy -legrand), 1999, 45(7) :943 -949.
5Schallreuter KU, Wood JM, Pittelkow MR, et al. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science, 1994, 263(5152) :1444 - 1446.
6Schallreuter KU, Buttner G, Pittelkow MR, et al. Cytotoxicity of 6-biopterin to human melanocytes. Biochem Biophys Res Commun,1994, 204( 1 ) :43 -48.
7Kalko SG, Gelpi JL, Fita I, et al. Theoretical study of the mechanisms of substrate recognition by catalase. J Am Chem Soc, 2001, 123(39) :9665 -9672.
8Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol, 1991,97(6) :1081- 1085.
9Beazley WD, Gaze D, Panske A, et al. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol,1999, 141(2) :301 -303.
10Maresca V, Roccella M, Roccella F, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol, 1997, 109(3) :310 -313.
